1. ALLA AKTIER
  2. NYHETER
  3. ORTIVUS

Ortivus

Nyheter Ortivus Nyheter alla bolag
Affiliate
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.

Ortivus’ Main Shareholder Ponderus Invest AB Extends Credit Facility Agreement with Ortivus

MARKN.

Following the publication yesterday of Ortivus’ interim report for the period 1 January – 30 June 2025, the company’s main shareholder, Ponderus Invest, has resolved to extend the existing credit facility to Ortivus by an additional SEK 10 million, a proposal which the company has accepted.

The additional lending may be drawn upon as required and carries the same terms as the previous loans, namely an interest rate of 8 per cent from the respective drawdown date. Repayment of any amounts utilised shall be made no later than 28 February 2026.

Prior to this extension, Ortivus’ borrowings from Ponderus Invest under the credit facility amounted to SEK 47.5 million.

The new facility provides the company with the necessary financial flexibility to continue product development and to pursue a more proactive market strategy, as outlined in yesterday’s interim report.

Contacts

For further information, please contact

Gustaf Nordenhök, CEO

Telefon +46 8 446 45 00

About Ortivus

Ortivus has extensive experience in mobile communication solutions and a unique understanding of clinical healthcare. We develop interactive and user-friendly solutions that support diagnostics, increase efficiency, and deliver long-term cost savings for healthcare providers. By integrating our solutions with electronic health records, dispatch systems, and national registries, we ensure fast and secure information management, a crucial factor in creating a more integrated care process. 
 
Our solutions save valuable time for healthcare professionals, optimise resource use, and reduce the need for avoidable patient transports, resulting in more cost-effective and patient-centred care. With our combination of advanced technology and deep clinical expertise, we support our customers in meeting the healthcare challenges of today and tomorrow.

Ortivus Class A and Class B shares are listed on the NASDAQ First North Growth Market and the company’s Certified Adviser is FNCA Sweden AB.
 
Read more about our solutions at www.ortivus.com

Attachments

Ortivus’ Main Shareholder Ponderus Invest AB Extends Credit Facility Agreement with Ortivus

Datum 2025-08-26, kl 10:15
Källa MFN
Bifogade filer
Ortivus’ Main Shareholder Ponderus Invest AB Extends Credit Facility Agreement with Ortivus